Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Artele Biosciences, Inc. on June 30, 2023. The company is incorporated in Nevada and its common stock (ARTL) and warrants (ARTLW) trade on The Nasdaq Stock Market, LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Meeting Attendance: Of 2,855,688 shares entitled to vote, 1,120,239 shares (39.2%) were represented, constituting a quorum.
Proposal 1: Election of Directors
All nominees were elected to their respective terms. The voting breakdown for each nominee is as follows:
| Nominee | Class | For | Against | Abstain | Broker Non-Vote |
|---|---|---|---|---|---|
| R. Martin Emanuele, Ph.D. | Class I | 307,104 | 39,589 | 60,889 | 712,657 |
| Steven Kelly | Class I | 299,201 | 40,895 | 67,486 | 712,657 |
| Douglas Blayney, M.D. | Class II | 279,185 | 59,443 | 68,954 | 712,657 |
| Connie Matsui | Class II | 291,763 | 40,856 | 74,963 | 712,657 |
| Gregory R. Ryes, M.D., Ph.D. | Class III | 307,036 | 40,166 | 60,380 | 712,657 |
| Tamara A. (Seymour) Favorito | Class III | 297,799 | 42,429 | 67,354 | 712,657 |
| Gregory D. Gorgas | Class III | 272,159 | 88,375 | 47,048 | 712,657 |
Proposal 2: Ratification of Auditors
The appointment of Malone Bailey LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023, was ratified.
- For: 1,049,839
- Against: 41,188
- Abstain: 29,212
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the specific terms of office for the newly elected directors (Class I: 1 year; Class II: 2 years; Class III: 3 years).
- Confirm the engagement letter and scope of work with Malone Bailey LLP for the 2023 fiscal year.
- Review the proxy statement for details on the significant number of broker non-votes (712,657) recorded for the director elections.
- Check subsequent filings for the company's financial status, as this 8-K contains no financial data.